(RTTNews) - Processa Pharmaceuticals, Inc. (PCSA), a clinical-stage pharmaceutical company, announced the successful completion of the safety tolerability evaluation in its Phase 1b trial of Next ...
SAN DIEGO--(BUSINESS WIRE)-- Gossamer Bio, Inc. (GOSS) (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the ...
Vancouver, British Columbia--(Newsfile Corp. - June 25, 2025) - Forge Resources Corp. (CSE: FRG) (OTCQB: FRGGF) (FSE: 5YZ) ("FRG" or the "Company"), is pleased to announce the successful completion of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback